Product News
INTEGRA Celebrates Success with the ASSIST PLUS at MipTec 2018
Product wins prestigious innovation award.
Product News
Riffyn Launches Open Access for Scientists at Non-Profits
To celebrate the ground-breaking publication of Riffyn SDE in the journal Scientific Data, Riffyn is launching Open Access which provides free use of the SDE for next-generation design and publishing of experiments.
Product News
Scientists Develop Recombinant Human Antibody Panel Against Snake Venom
Paper published in Nature Communications shows the potential of applying modern recombinant antibody technology to the blight of snake envenomation.
Product News
Synthace Launches Ground-Breaking New Whitepaper
Comprehensive report heralds the beginning of Computer Aided Biology (CAB).
Product News
PerkinElmer Receives FDA Clearance for NeoBase™ 2 Non-Derivatized Tandem Mass Spectrometry Kit
In vitro diagnostic solution tests newborn babies for a variety of metabolic disorders with a single dried blood spot card.
Product News
New Flash Purification System and Columns from Biotage
Company introduces new Biotage® Selekt and Biotage® Sfär.
Product News
OCEASOFT Launches Colbalt X2, its New-Generation System for Monitoring Physical Parameters
OCEASOFT brings a new dimension to solutions for monitoring physical parameters such as temperature, humidity, and more.
Product News
CellOPTIQ® High Content Assay Confirmed as Leader in Assessing Cardiotoxicity
A major international FDA-led study confirms CellOPTIQ® High Content Assay as leading in vitro platform to assess cardiotoxicity in new drugs.
Product News
Take Full Advantage of Versatility: Eppendorf SmartExtender Now Available
Eppendorf SmartExtender with SmartBlocks offers a comfortable incubation tool for handling all common vessels.
Product News
Foundation Medicine Introduces FoundationOne®Liquid, the Latest Advance in the Company’s Liquid Biopsy Test for Solid Tumors in Patients with Advanced Cancer
oundationOne Liquid analyzes 70 genes known to drive cancer growth and reports microsatellite instability high (MSI-high) status to inform the use of precision oncology treatments, including immunotherapies, with a simple blood draw.
Advertisement